76313158 - MIRROR IMAGE

Information

• Trademark
• 76313158

• Source

• Serial Number

  76313158

• Registration Number

  2694903

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  September 17, 2001
  23 years ago

• Registration Date

  March 11, 2003
  21 years ago

• Transaction Date

  August 10, 2011
  13 years ago

• Status Date

  October 17, 2009
  15 years ago

• Published for Opposition Date

  December 17, 2002
  21 years ago

• Location Date

  May 28, 2008
  16 years ago

• Status Code

  710

• Current Location

  SCANNING ON DEMAND

  Employee Name

  ESTRADA, LINDA M

• Attorney Docket Number

  BOH6278T0030

  Attorney Name

  Lisa V. Mueller

  Law Office Assigned Location Code

  L50

• Owners

  • Noxxon Pharma AG

Case File Statements

• GS0011: Chemical products, namely polynucleotides, preferably containing at least one L-nucleotide, polypeptides, preferably containing at least one D-amino acid, compounds consisting in whole or in part of nucleic acids or derivatives thereof, for industrial, scientific, agricultural, gardening and forestry purposes; D- and L- nucleotides for use in manufacturing pharmaceuticals; L- and D- amino acids for use in manufacturing pharmaceuticals
• GS0051: Pharmaceutical and veterinary products, namely, preparations for sanitation, slimming, appetite suppressants, pharmaceuticals for acidosis therapeutics, analeptic and antihypoxaemics; analgetics and antirheumatic drugs, pharmaceuticals functioning as antihelmintics, antiallergics, antianemia drugs, antiarrhythmics, antibiotics and antiinfectives, antidementics, nootropics, antidiabetics, antidotes for the treatment of poisoning, antiemetics and antivertiginosics, antiepileptics, antihemorrhagics, antifibrinolyrics, hemostatics, antihypertonics, antihypoglycemics, antihypotonics, anticoagulants, antimycotics, pharmaceuticals functioning as antiparasitics, antiphlogistics, antitussives, expectorants for use in atherosclerosis, balneotherapeutics and pharmaceuticals for thermal therapy, pharmaceuticals functioning as beta receptor blocking agents, pharmaceuticals for calcium channel blocking and inhibiting of the renin angiotensin-system, pharmaceuticals functioning as broncholytics and antiasthmetics cholagoguegics and for use in biliary tract therapeutics; pharmaceuticals functioning as cholinergics, corticoids, dermatics; all purpose disinfectants and antiseptics; pharmaceuticals functioning as dietetic agents and in alimentary therapeutics; diagnostic preparations functioning as diuretics, as agents for favoring blood flow, as withdrawal agents, as fibrinolytics, to treat gout, the flu and catarrhal fever; pharmaceuticals for the treatment of gynecological illnesses, namely, menstrual cramps, hemorrhoids, hepatitis; pharmaceuticals functioning as hypnotics and sedatives; pharmaceuticals to treat cardiac ailments; pharmaceuticals for use in caries and parodontosis; dental preparations, namely, dental abrasives; laxatives, pharmaceuticals functioning as antilipaemics, local anaesthetics, neural therapeutics, gastro-intestinal preparations, pharmaceuticals to treat migraines; pharmaceutical preparations for use in mouth and pharyngeal therapeutics; pharmaceuticals for use as muscle relaxants; pharmaceuticals for the treatment of addiction to narcotics; pharmaceuticals for use in neuropathology; ophthalmic pharmaceuticals for treating blindness, conjunctivitis, cataract, glaucoma, retinal detachment, stye, chalazion, dacryoadenitis, corneal clouding, keratitis, gasserian ganglionitis, vitreous opacity, amaurosis, retinopathy, central retinal artery occlusion, retinoblastoma, melanoma, optic neuritis, optic nerve atrophy; pharmaceuticals for use osteoporosis and calcium metabolism modification; pharmaceuticals for the treatment of Parkinson's Disease and disturbances of the extrapyramidal system; pharmaceuticals for psychotropic, rhinologic and sinositic purposes; pharmaceuticals functioning as roborants and tonics; pharmaceuticals for use in thyroidal therapeutics; pharmaceuticals functioning as spasmolytics and inhibitors of thrombocyte aggregation; pharmaceuticals for the treatment of tuberculosis; pharmaceuticals functioning as alternants, urologics and venous agents; vitamins; pharmaceuticals for use as cytostatics and antineoplastic agents; homeopathic remedies, and medical plastics, namely sanitary preparations
• GS0091: Scientific, electronic, photographic, optical, measuring, signaling and controlling apparatus and instruments, namely, analytical devices comprising polynucleotides, polypeptides or polynucleotides and polypeptides as detection means; magnetic data medium, namely tapes, discs, diskettes and CDs, preferably containing sequence data on polynucleotides, polypeptides or polynucleotides and polypeptides; computers; computer software for designing target specific polynucleotides and polypeptides and software for use in the field of synthesis of nucleic acids and peptides, proteins and control of synthesis machines
• GS0421: Research and product development services for others in the filed of veterinary medicine, human medicine and agriculture; research and product development for others in the science and medical industries; computer services, namely, designing programs for others in data processing; chemistry consultation; biology consultation; biochemistry consultation; biotechnology consultation; gene technologies consultation; molecular biology consultation; pharmaceutical advice; medical services, veterinary services

Case File Event Statements

• 10/17/2009 - 15 years ago

  17 - CANCELLED SEC. 8 (6-YR) Type: C8..

• 5/28/2008 - 16 years ago

  16 - CASE FILE IN TICRS Type: CFIT

• 10/24/2007 - 17 years ago

  15 - REVIEW OF CORRESPONDENCE COMPLETE Type: CORV

• 10/18/2007 - 17 years ago

  14 - PAPER RECEIVED Type: MAIL

• 9/10/2006 - 18 years ago

  13 - REVIEW OF CORRESPONDENCE COMPLETE Type: CORV

• 6/18/2004 - 20 years ago

  12 - PAPER RECEIVED Type: MAIL

• 3/11/2003 - 21 years ago

  11 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 12/17/2002 - 21 years ago

  10 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/27/2002 - 21 years ago

  9 - NOTICE OF PUBLICATION Type: NPUB

• 9/16/2002 - 22 years ago

  8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/9/2002 - 22 years ago

  7 - EXAMINERS AMENDMENT MAILED Type: CNEA

• 5/28/2002 - 22 years ago

  6 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/22/2002 - 22 years ago

  5 - Sec. 1(B) CLAIM DELETED Type: 1.BD

• 5/28/2002 - 22 years ago

  4 - PAPER RECEIVED Type: MAIL

• 5/22/2002 - 22 years ago

  3 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/26/2001 - 23 years ago

  2 - NON-FINAL ACTION MAILED Type: CNRT

• 11/16/2001 - 23 years ago

  1 - ASSIGNED TO EXAMINER Type: DOCK